Unknown PHASE1 INTERVENTIONAL 2-arm NCT05232994

Metformin and Esomeprazole For Preterm Pre-eclampsia

Use of Combination Metformin and Esomeprazole in Preterm Pre- Eclampsia: Randomized Controlled Trial

Sponsor: Christiana Care Health Services

Conditions Preeclampsia Second Trimester Preeclampsia Severe Preterm Birth Complication

Updated 8 times since 2022 Last updated: Feb 9, 2023 Started: Mar 1, 2023 Primary completion: Dec 31, 2024 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Preeclampsia Second Trimester and Preeclampsia Severe, this trial is ongoing. The trial is conducted by Christiana Care Health Services and has accumulated 8 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Feb 2026 — Present [monthly]

Unknown PHASE1

Status: Not Yet Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Not Yet Recruiting PHASE1
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE1
Mar 2023 — Jul 2024 [monthly]

Not Yet Recruiting PHASE1
Dec 2022 — Mar 2023 [monthly]

Not Yet Recruiting PHASE1

▶ Show 3 earlier versions

Sep 2022 — Dec 2022 [monthly]

Not Yet Recruiting PHASE1
Jun 2022 — Sep 2022 [monthly]

Not Yet Recruiting PHASE1
Mar 2022 — Jun 2022 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Christiana Care Health Services

Data source: Christiana Care Health Services

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Newark, United States